Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis
Authors:
Open Access
- 19 September 2023
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 196, 106934
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
This publication has 50 references indexed in Scilit:
- Blood–brain barrier structure and function and the challenges for CNS drug deliveryJournal of Inherited Metabolic Disease, 2013
- Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody CetuximabClinical Cancer Research, 2011
- Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain MetastasisThe American Journal of Pathology, 2010
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1Proceedings of the National Academy of Sciences, 2010
- Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based ReviewJournal of Clinical Oncology, 2010
- Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cellsMolecular Cancer Therapeutics, 2008
- Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonizationClinical & Experimental Metastasis, 2008
- Protective Role of Reactive Astrocytes in Brain IschemiaJournal of Cerebral Blood Flow & Metabolism, 2007
- Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncologyAnnals of Oncology, 2005
- Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New EntityJournal of Clinical Oncology, 2005